IT201700027628A1 - Composizione per uso nella riduzione della crescita dei peli - Google Patents

Composizione per uso nella riduzione della crescita dei peli

Info

Publication number
IT201700027628A1
IT201700027628A1 IT102017000027628A IT201700027628A IT201700027628A1 IT 201700027628 A1 IT201700027628 A1 IT 201700027628A1 IT 102017000027628 A IT102017000027628 A IT 102017000027628A IT 201700027628 A IT201700027628 A IT 201700027628A IT 201700027628 A1 IT201700027628 A1 IT 201700027628A1
Authority
IT
Italy
Prior art keywords
peli
growth
reducing
composition
reducing peli
Prior art date
Application number
IT102017000027628A
Other languages
English (en)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102017000027628A priority Critical patent/IT201700027628A1/it
Priority to CN201880017130.2A priority patent/CN110612099A/zh
Priority to EP18717420.6A priority patent/EP3595650B1/en
Priority to RU2019132062A priority patent/RU2019132062A/ru
Priority to ES18717420T priority patent/ES2883424T3/es
Priority to PCT/IB2018/051651 priority patent/WO2018167657A1/en
Publication of IT201700027628A1 publication Critical patent/IT201700027628A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
IT102017000027628A 2017-03-13 2017-03-13 Composizione per uso nella riduzione della crescita dei peli IT201700027628A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT102017000027628A IT201700027628A1 (it) 2017-03-13 2017-03-13 Composizione per uso nella riduzione della crescita dei peli
CN201880017130.2A CN110612099A (zh) 2017-03-13 2018-03-13 用于减少毛发生长的组合物
EP18717420.6A EP3595650B1 (en) 2017-03-13 2018-03-13 Composition for use in the reduction of hair growth
RU2019132062A RU2019132062A (ru) 2017-03-13 2018-03-13 Композиция для уменьшения роста волос
ES18717420T ES2883424T3 (es) 2017-03-13 2018-03-13 Composición para su uso en la reducción del crecimiento del vello
PCT/IB2018/051651 WO2018167657A1 (en) 2017-03-13 2018-03-13 Composition for use in the reduction of hair growth

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000027628A IT201700027628A1 (it) 2017-03-13 2017-03-13 Composizione per uso nella riduzione della crescita dei peli

Publications (1)

Publication Number Publication Date
IT201700027628A1 true IT201700027628A1 (it) 2018-09-13

Family

ID=59521437

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000027628A IT201700027628A1 (it) 2017-03-13 2017-03-13 Composizione per uso nella riduzione della crescita dei peli

Country Status (6)

Country Link
EP (1) EP3595650B1 (it)
CN (1) CN110612099A (it)
ES (1) ES2883424T3 (it)
IT (1) IT201700027628A1 (it)
RU (1) RU2019132062A (it)
WO (1) WO2018167657A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112386697A (zh) * 2019-08-16 2021-02-23 中国科学院分子细胞科学卓越创新中心 以3βHSD为靶点的激素依赖性疾病预防和治疗药物和方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003687A2 (en) * 1999-07-13 2001-01-18 Cedars-Sinai Medical Center Method and compositions for inhibiting biosynthesis or bioactivity of endogenous steroid sex hormones in humans
EP1074240A2 (en) * 1999-07-27 2001-02-07 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
EP1314438A1 (en) * 2001-11-23 2003-05-28 Nutricia N.V. Anti-proliferative composition
US20050037099A1 (en) * 2003-08-15 2005-02-17 Leonid Markman Hydrolysis and purification of active plant compounds suitable for topical application
WO2009052518A2 (en) * 2007-10-19 2009-04-23 Aspen Benefits Group, Llc Methods and compositions directed to reduction of facial hair hirsutism in females
WO2012131638A1 (en) * 2011-04-01 2012-10-04 Funcional Food Research S.R.L. Functional food for male use including muirapuamine and yohimbine

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003687A2 (en) * 1999-07-13 2001-01-18 Cedars-Sinai Medical Center Method and compositions for inhibiting biosynthesis or bioactivity of endogenous steroid sex hormones in humans
EP1074240A2 (en) * 1999-07-27 2001-02-07 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
EP1314438A1 (en) * 2001-11-23 2003-05-28 Nutricia N.V. Anti-proliferative composition
US20050037099A1 (en) * 2003-08-15 2005-02-17 Leonid Markman Hydrolysis and purification of active plant compounds suitable for topical application
WO2009052518A2 (en) * 2007-10-19 2009-04-23 Aspen Benefits Group, Llc Methods and compositions directed to reduction of facial hair hirsutism in females
WO2012131638A1 (en) * 2011-04-01 2012-10-04 Funcional Food Research S.R.L. Functional food for male use including muirapuamine and yohimbine

Also Published As

Publication number Publication date
EP3595650B1 (en) 2021-04-28
WO2018167657A1 (en) 2018-09-20
RU2019132062A (ru) 2021-04-14
CN110612099A (zh) 2019-12-24
ES2883424T3 (es) 2021-12-07
EP3595650A1 (en) 2020-01-22

Similar Documents

Publication Publication Date Title
BR112016011830A2 (pt) composições bacterianas sinergísticas e métodos para produção e uso das mesmas.
EP3328414A4 (en) COMPOSITION FOR USE IN PROMOTING WOUND HEALING
SG11201507438YA (en) Polishing composition, method for producing polishing composition and polishing composition preparation kit
EP2979687A4 (en) ARTIFICIAL NAIL COMPOSITION, ARTIFICIAL NAIL, METHOD OF FORMING ARTIFICIAL NAIL, AND NAIL DECORATION KIT
HK1216146A1 (zh) 眼藥組合物、其製備方法及用途
EP2966445A4 (en) TINTANT FOR DYING OF TISSUE, MANUFACTURING PROCESS FOR TINTING AGENT FOR TISSUE AND TISSUE COLORING TINTANT FOR TISSUE COLORING
EP3050555A4 (en) ARTIFICIAL NAIL COMPOSITION, ARTIFICIAL NAIL, AND FORMATION METHOD THEREOF, AND UNIPULAR ART KIT
EP3038621A4 (en) Compounds and matrices for use in bone growth and repair
EP3167761A4 (en) Legged fixture, and leg adjuster and leg adjuster set for use in same
CL2016000351A1 (es) Método para la cuantificación de actinio-227 en composiciones de radio-223.
HRP20190328T1 (hr) Pripravak za topikalnu primjenu u slušnom kanalu
BR112015027026A2 (pt) composição para uso na redução da formação de crosta e na promoção da cicatrização
IL269406A (en) Preparations containing microalgae that have been grown in a controlled process for use in dyeing processes
DK3743721T3 (da) Minaprin til anvendelse til reducering af tumorvækst
HK1223542A1 (zh) 眼用組合物及其試劑盒
CL2016000998A1 (es) Composición herbaria, procedimiento para su preparación y uso de la misma
EP2950646A4 (en) AGROCHEMICAL COMPOSITION, PROCESS FOR PREPARATION AND USE THEREOF
CL2017002726A1 (es) Método cosmético y uso terapéutico para la reducción de grasa
BR112015021722A2 (pt) composição para uso no tratamento de síndrome do ovário policístico
EP3378466A4 (en) COMPOSITION FOR USE IN ORAL CAVITY
EP3304041A4 (en) Methods of assessing cellular breast samples and compositions for use in practicing the same
IT201700037319A1 (it) Composizione naturale per uso in ginecologia
IT201700027628A1 (it) Composizione per uso nella riduzione della crescita dei peli
IT201700006360A1 (it) Composizione per uso oftalmico
IT201700040834A1 (it) Composizioni comprendenti oli essenziali per uso topico